[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-344832-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-344832-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","evidence-that-extra-copies-of-chromosome-1q-play-a-role-in-the-early-phases-of-pancreatic-neoplasia","Evidence that extra copies of chromosome 1q play a role in the early phases of pancreatic neoplasia","","Evidence links increases in chromosome 1q copy number to the initiation of pancreatic ductal adenocarcinoma. Whole-genome sequencing of 535 PDACs showed 1q gains as the second most frequent event (213/535, 39.8%). Single-cell fluorescence in situ hybridization on 33 cancers confirmed that a subset of 1q is gained, narrowing two ~3-megabase regions containing NCSTN and PSEN2. Analysis of 267 precancerous lesions found extra copies of these genes common (49%) in high-grade pancreatic intraepithelial neoplasia and rare (6%) in low-grade lesions. The results support γ-secretase genes as genetically activated oncogenes in early pancreatic neoplasia.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/evidence-that-extra-copies-of-chromosome-1q-play-a-role-in-the-early-phases-of-pancreatic-neoplasia/344832/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/evidence-that-extra-copies-of-chromosome-1q-play-a-role-in-the-early-phases-of-pancreatic-neoplasia/344832.png","ImageObject",300,407,{"name":42,"@type":43},"Lucas Martin","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-28","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",8,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What role do extra copies of chromosome 1q play in pancreatic neoplasia?","Question",{"text":63,"@type":64},"Extra copies of chromosome 1q are linked to early phases of pancreatic neoplasia. The study narrows the effect to specific 1q regions that are frequently gained in PDACs and certain precancerous lesions.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"Which genes within 1q are highlighted by the findings?",{"text":68,"@type":64},"The highlighted regions contain NCSTN and PSEN2, which encode subunits of the γ-secretase complex. Extra copies of these genes are common in high-grade pancreatic intraepithelial neoplasms.",{"name":70,"@type":61,"acceptedAnswer":71},"How do the gene copy number patterns differ between lesion grades?",{"text":72,"@type":64},"Extra copies of NCSTN and PSEN2 are common (49%) in noninvasive, high-grade lesions, but uncommon (6%) in low-grade pancreatic intraepithelial neoplasia, consistent with higher malignant progression risk in the former.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},344832,1790183327,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":55,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":112,"preview_page_count":33,"preview_urls":145},8796095360427,"https://ap-avatar.wpscdn.com/davatar_994ba38a5ba835b3df7d355c54d3ed8d","GENETICS  \nEvidence that extra copies of chromosome 1q play a role in the early phases of pancreatic neoplasia  \nChristopher Douville1,2,3,4*, Jeeun Parksong1,5, Marco Dal Molin1,6, Sarah Graham1,5, Patricia T. Greipp7, Ryan Knudson7, Samuel Curtis1,2,3,4, Yuxuan Wang1,2,3,4, Lisa Dobbyn1,3,4, Maria Popoli1,2,3,4, Janine Ptak1,2,3,4,8, Natalie Silliman1,2,3,4,8, Katharine Romans1,2,3,4, Christine A. Iacobuzio-Donahue9, Alvin P. Makoohon-Moore10, Anne Marie Lennon11, Michael Goggins1,2,3,4,5, Ralph H. Hruban5, Ashley Kiemen5, Chetan Bettegowda1,2,3,4,5,12,  \nKenneth W. Kinzler1,2,3,4, Nickolas Papadopoulos1,2,3,4,5, Laura D. Wood1,5*, Bert Vogelstein1,2,3,4,5,8*  \nWe searched for oncogenes activated by copy number increases using whole-genome sequencing data of 535 pancreatic ductal adenocarcinomas (PDACs). We found that gains of 1q were the second most common gain, occurring in 213 (39.8%) of PDACs. Single-cell analysis via fluorescence in situ hybridization on 33 cancers confirmed these results. A portion of 1q, rather than the entire 1q arm, was gained in 75 (14.0%) PDACs, allowing us to pinpoint two ~3-megabase regions of 1q that were nearly always gained. These two regions contained NCSTN and PSEN2, genes that code two subunits of the γ-secretase complex. Evaluation of 267 precancerous lesions revealed that extra copies of NCSTN and PSEN2 were common (49%) in noninvasive neoplasms (high-grade pancreatic intraepithelial neoplasms), which are at relatively high risk for progression to PDACs, but uncommon (6%) in low-grade pancreatic intraepithelial neoplasia lesions, which have low malignant potential. We hypothesize that γ-secretase genes are genetically activated oncogenes in the early phases of pancreatic neoplasia.  \ncopyright © 2026 the Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. no claim to original U.S.  \nGovernment Works. Distributed under a creative commons Attribution license 4.0 (cc BY) .  \nINTRODUCTION  \nIt is estimated that pancreatic ductal adenocarcinomas (PDACs) will strike 67,440 Americans in 2025, and the 5-year survival rate is only 13%(1–3). These cancers arise in the pancreatic ducts systems and are generally driven by somatic genetic activation of an oncogene (KRAS) coupled with genetic inactivation of two or three tumor suppressor genes (CDKN2A, TP53, and SMAD4) (4, 5). Activated oncogenes, including KRAS, can be directly targeted by drugs that bind to and inactivate their protein products. This drug-based strategy is generally not applicable to tumor suppressor genes because the proteins encoded by mutant tumor suppressor genes are, in many cases, absent in cancer cells (6). Even when such tumor suppressor proteins are present, it is more difficult to pharmacologically activate an inactive protein than to inactivate the function of an active protein (3). Thus, virtually all  \n1Department of Oncology, the Sidney Kimmel cancer center, Johns hopkins University School of Medicine, 733 n. Broadway, Baltimore, MD 21205, USA. 2the ludwig center, Johns hopkins University School of Medicine, 733 n. Broadway, Baltimore, MD 21205, USA. 3the Sol Goldman Pancreatic cancer Research center, Johns hopkins University School of Medicine, 733 n. Broadway, Baltimore, MD 21205, USA. 4Sidney Kimmel comprehensive cancer center, Johns hopkins University School of Medicine, Baltimore, MD 21287, USA. 5Department of Pathology, Johns hopkins University School of Medicine, 733 n. Broadway, Baltimore, MD 21205, USA. 6Department of Surgery, Johns hopkins University School of Medicine, 733 n. Broadway, Baltimore, MD 21205, USA. 7Department of laboratory Medicine and Pathology, Mayo clinic, 200 First Street SW, Rochester, Mn 55905, USA. 8the howard hughes Medical institute, Johns hopkins University School of Medicine, 733 n. Broadway, Baltimore, MD 21205, USA. 9Department of Pathology, Memorial Sloan Kettering cancer center, 417 est 68th Street new York, nY 10065, USA. 10cent","cbCaibjDlFwABQo8","https://ap.wps.com/l/cbCaibjDlFwABQo8","pdf",922208,12,"English","# Introduction\n## Early genetic events in pancreatic ductal adenocarcinoma\n## Targeted therapy and tumor suppressor gene challenges\n## Rationale for earlier detection","[{\"question\":\"What role do extra copies of chromosome 1q play in pancreatic neoplasia?\",\"answer\":\"Extra copies of chromosome 1q are linked to early phases of pancreatic neoplasia. The study narrows the effect to specific 1q regions that are frequently gained in PDACs and certain precancerous lesions.\"},{\"question\":\"Which genes within 1q are highlighted by the findings?\",\"answer\":\"The highlighted regions contain NCSTN and PSEN2, which encode subunits of the γ-secretase complex. Extra copies of these genes are common in high-grade pancreatic intraepithelial neoplasms.\"},{\"question\":\"How do the gene copy number patterns differ between lesion grades?\",\"answer\":\"Extra copies of NCSTN and PSEN2 are common (49%) in noninvasive, high-grade lesions, but uncommon (6%) in low-grade pancreatic intraepithelial neoplasia, consistent with higher malignant progression risk in the former.\"}]","Evidence that extra copies of chromosome 1q play a role in the early phases of pancreatic neoplasia | PDF",1790055399,[146,150,154,158],{"page_no":22,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/496c2b09ac6d1fb7bbbd0b432e19178b.webp",983,1250,{"page_no":26,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3948f9a2afee8baa016e46de97555f0a.webp",982,1249,{"page_no":30,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7ce81fde3f4e2242a05277fd5ca54a14.webp",981,1248,{"page_no":33,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/433ae69b2078713a0fec323115123590.webp",980,1247]